NASDAQ:PDEX

Pro-Dex Stock Forecast, Price & News

$29.08

+0.10 (+0.35 %)

(As of 06/21/2021 12:00 AM ET)

Add

Compare

Today's Range

$29.00

▼

$29.85

50-Day Range

$25.76

▼

$35.80

52-Week Range

$16.76

▼

$42.60

Volume9,976 shs

Average Volume26,308 shs

Market Capitalization$106.08 million

P/E Ratio29.58

Dividend YieldN/A

Beta1.2

30 days | 90 days | 365 days | Advanced Chart

Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

About Pro-Dex

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

The Pro-Dex (NASDAQ:PDEX) Share Price Has Soared 557%, Delighting Many Shareholders
June 16, 2021 | nasdaq.com

Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200-Day Moving Average of $0.00
June 11, 2021 | americanbankingnews.com

Pro-Dex, Inc. Discusses Record Third Quarter Sales and Aggressive Growth Strategy with The Stock Day Podcast
June 3, 2021 | finance.yahoo.com

Returns On Capital Are Showing Encouraging Signs At Pro-Dex (NASDAQ:PDEX)
May 28, 2021 | finance.yahoo.com

Pro-Dex (NASDAQ:PDEX) Shareholders Will Want The ROCE Trajectory To Continue
May 25, 2021 | nasdaq.com

7 Best Event Driven Opportunities
May 9, 2021 | seekingalpha.com

Pro-Dex EPS beats by $0.28, beats on revenue
May 8, 2021 | seekingalpha.com

Pro-Dex, Inc. Announces Fiscal 2021 Third Quarter and Nine-Month Results
May 6, 2021 | finanznachrichten.de

How Much Of Pro-Dex, Inc. (NASDAQ:PDEX) Do Institutions Own?
April 28, 2021 | finance.yahoo.com

What Does Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Indicate?
March 29, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PDEX
Previous Symbol
CUSIPN/A
CIK788920
Webwww.pro-dex.com
Phone949-769-3200
Employees117
Year FoundedN/A

Sales & Book Value

Annual Sales$34.83 million
Price / Sales3.05
Cash Flow$1.56 per share
Price / Cash Flow18.65
Book Value$4.92 per share
Price / Book5.91

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares3,648,000
Market Cap$106.08 million
Next Earnings Date8/5/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.73 out of 5 stars

Medical Sector

1293rd out of 2,105 stocks

Surgical & Medical Instruments Industry

117th out of 174 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pro-Dex.

2.2 Community Rank

Outperform Votes
Pro-Dex has received 88 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pro-Dex has received 109 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pro-Dex has received 55.33% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pro-Dex and other stocks. Vote “Outperform” if you believe PDEX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PDEX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pro-Dex does not currently pay a dividend.
Dividend Growth
Pro-Dex does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $33,154.00 in company stock.
Percentage Held by Insiders
40.80% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 22.40% of the stock of Pro-Dex is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Pro-Dex is 29.58, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.46.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pro-Dex is 29.58, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 43.66.
Price to Book Value per Share Ratio
Pro-Dex has a P/B Ratio of 5.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

What stocks does MarketBeat like better than Pro-Dex?

Wall Street analysts have given Pro-Dex a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Pro-Dex wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Pro-Dex's next earnings date?

Pro-Dex is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Pro-Dex.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) announced its earnings results on Friday, May, 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.28. The medical instruments supplier earned $11.74 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 30.20% and a net margin of 15.47%.
View Pro-Dex's earnings history.

How has Pro-Dex's stock been impacted by Coronavirus (COVID-19)?

Pro-Dex's stock was trading at $18.24 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PDEX stock has increased by 59.4% and is now trading at $29.08.
View which stocks have been most impacted by COVID-19.

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the following people:

Mr. Richard Lee Van Kirk Jr., CEO, Pres, COO & Director (Age 60, Pay $621.64k)
Ms. Alisha K. Charlton, CFO & Corp. Sec. (Age 51, Pay $248.95k)

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex CEO Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among Pro-Dex's employees.

Who are some of Pro-Dex's key competitors?

Some companies that are related to Pro-Dex include Accuray (ARAY), ClearPoint Neuro (CLPT), InfuSystem (INFU), Profound Medical (PROF), Retractable Technologies (RVP), Apyx Medical (APYX), IRadimed (IRMD), Cytosorbents (CTSO), DarioHealth (DRIO), The Westaim (WEDXF), Utah Medical Products (UTMD), Co-Diagnostics (CODX), Apollo Endosurgery (APEN), TELA Bio (TELA) and Nemaura Medical (NMRD).
View all of PDEX's competitors.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by a variety of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (2.30%), BlackRock Inc. (1.57%), Dimensional Fund Advisors LP (1.60%), Victory Capital Management Inc. (1.33%), LSV Asset Management (0.85%) and Geode Capital Management LLC (0.79%). Company insiders that own Pro-Dex stock include Alisha Charlton, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III.
View institutional ownership trends for Pro-Dex.

Which major investors are selling Pro-Dex stock?

PDEX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Northern Trust Corp, Acadian Asset Management LLC, O Shaughnessy Asset Management LLC, and LSV Asset Management. Company insiders that have sold Pro-Dex company stock in the last year include Alisha Charlton, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot, and William James Farrell III.
View insider buying and selling activity for Pro-Dex or view top insider-selling stocks.

Which major investors are buying Pro-Dex stock?

PDEX stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Exchange Traded Concepts LLC, Fiera Capital Corp, Punch & Associates Investment Management Inc., Hussman Strategic Advisors Inc., Dimensional Fund Advisors LP, Geode Capital Management LLC, and BlackRock Inc..
View insider buying and selling activity for Pro-Dex or or view top insider-buying stocks.

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $29.08.

How much money does Pro-Dex make?

Pro-Dex has a market capitalization of $106.08 million and generates $34.83 million in revenue each year.

How many employees does Pro-Dex have?

Pro-Dex employs 117 workers across the globe.

What is Pro-Dex's official website?

The official website for Pro-Dex is www.pro-dex.com.

Where are Pro-Dex's headquarters?

Pro-Dex is headquartered at 2361 MCGAW AVENUE, IRVINE CA, 92614.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at 949-769-3200 or via email at [email protected]

This page was last updated on 6/22/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here